Familial hypercholesterolaemia: open trials in Austria

• 2024-514595-41-00

  Study to evaluate efficacy and safety of inclisiran in children aged 2 to under 12 years of age with homozygous familial hypercholesterolemia

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Medical University of Vienna, Vienna

  Registry updated 2026-10-26

• NCT06597006

  Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Vienna

  Registry updated 2026-07-24

• 2026-525917-29-00

  Early TRIPLE versus dual LIPID lowering treatment in peOple with atherosclerotic cardiovascular disease and hypercholesterolemia Undergoing elecTive revascularisation

  Trial Treatment · Phase 4 · Medical University Of Graz

  VIVIT, Feldkirch · Medical University of Graz, Graz · Steiermaerkische Krankenanstalten Ges.m.b.H., Graz · Landeskrankenanstalten-Betriebsgesellschaft Kabeg, Klagenfurt Am Woerthersee

  Registry updated 2026-07-17

• NCT06597019

  Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Salzburg · Vienna

  Registry updated 2026-05-15

All Familial hypercholesterolaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error